Editor Profiles

Anna Clark, Editor

New Content ItemAnna is a Senior Editor for the BMC-series and has been the Editor of BMC Psychiatry since March 2015. Before joining BioMed Central, Anna received her PhD in Neuroscience from King's College London, UK and was a post-doctoral fellow for a number of years. Anna’s interests for ‘all things brainy’ stem from her undergraduate studies at University College London, UK where she developed a keen interest in psychopharmacology, which led to her passion for pain; a PhD and subsequent post-docs (King's College London, UK and Medical University of Vienna, Austria) where she studied neuron-immune cell interactions in chronic pain conditions. Anna is involved in a trial of ‘Results-free peer-review’ which is currently running on BMC Psychology; the trial is aiming to improve the quality of published research by focusing editorial decisions on the scientific merits of the rationale and validity of study design. Anna also writes on the BioMed Central blog network and is an Editor of the BMC Series blog​​​​​​​​​​​​​​

Section Editors

Cathy Barr

Back to top

New Content ItemPsychiatric molecular genetics


Dr. Cathy Barr, Ph.D. is Senior Scientist Hospital for Sick Children, Senior Scientist Krembil Research Institute, University Health Network, and Professor in the Departments of Psychiatry and Physiology at The University of Toronto. She joined the Editorial Board of BMC Psychiatry as Section Editor in 2011. 

Dr. Barr completed her Ph.D. in molecular biology at the University of Texas, Graduate School of Biomedical Sciences (M.D. Anderson Hospital) in Houston, Texas.  She then pursued her postdoctoral training in the genetics of complex behaviors at Yale University and subsequently at the Hospital for Sick Children in Toronto. 

Dr. Barr’s research is focused on the study of childhood-onset psychiatric and cognitive disorders and functional studies of associated genes including CRISPR/Cas9 editing of gene regulatory elements to determine the role of genetic risk alleles on gene expression


Secondo Fassino

Back to top

New Content ItemEating disorders


Secondo Fassino, M.D., is Full Professor of Psychiatry at the University of Turin, Italy, where he instructs medical students and residents. He is a certified psychiatrist specialized in treating individuals with anorexia nervosa, bulimia nervosa, binge eating disorder, and personality disorders. He earned his medical degree from the University of Turin, Italy, where he also completed the residency in psychiatry. Since 2002 he is the Director of the Eating Disorder Center of the University of Turin, Italy. He authored and co-authored more than 150 articles and publications. He has been the Section Editor of the Eating Disorders section of BMC Psychiatry since 2011. His main clinical and research interests encompass: eating and personality disorders, psychotherapy, pharmacotherapy, psychodynamic psychiatry


Seena Fazel

Back to top

New Content ItemForensic psychiatry


Seena Fazel is a Wellcome Trust senior research fellow in clinical science at the University of Oxford, and a consultant forensic psychiatrist at Oxford Health NHS Foundation Trust, UK. His research focuses on relationships between severe mental illness and violent crime, and the mental health and suicide risk of prisoners. He has served on advisory boards for NHS research funding committees and the crime reduction charity NACRO, and given evidence to the UK Government Justice Select Committee and the UN-backed Khmer Rouge war crimes tribunal. He joined the Editorial Board of BMC Psychiatry as Section Editor in 2015


Sharon Lawn

Back to top

New Content ItemSocial psychiatry, therapy and provision of mental health care


Sharon Lawn is Director of Flinders Human Behaviour and Health Research Unit in the Department of Psychiatry at Flinders University. She joined the Editorial Board of BMC Psychiatry as Section Editor in 2015. Sharon and her team undertake research in chronic condition management and self-management support, digital health to support health behaviour change, primary healthcare and mental health. She is highly active in mental health movement in Australia and brings multi-disciplinary skills and experience from being a health clinician for more than 23 years. Her research uses a broad range of qualitative and mixed methods, and focuses on examining the culture of service provision, systems of care, the healthcare workforce and interprofessional education and practice, implementation issues, smoking cessation and smoke-free policy in mental health settings, and service users’ experiences of care


Ute Lewitzka

Back to top

New Content ItemCauses, treatment and prevention of suicide


Ute Lewitzka is a senior physician in the Department of Psychiatry and Psychotherapy at the University Hospital Dresden, Germany. She is the head of the working group for Suicide Research.

Dr. Lewitzka graduated in medicine at the Technische Universität Dresden, Germany.  She completed her doctoral thesis in neurobiology investigating neurobiological parameters in the blood of suicide attempters. From 2010 to 2012 she received a grant from Dalhousie University in Halifax, Canada and worked together with Prof. Anne Duffy at the Department of Psychiatry focusing on suicidality as it relates to the early course of mood disorders in youth and young adults.

Her current research focuses on the acute suicide-preventing effect of lithium in patients with affective disorders. She leads research projects such as an investigation about the attitude towards suicide in doctors, the impact of lithium intoxication on kidney function, the evaluation of possible suicide hot spots in Dresden and many others.

Dr. Lewitzka is a member of the board of the German Association for Suicide Prevention where she is connected to many stakeholders of suicide research as well as prevention in Germany. She also is engaged in an international lithium research group (IGSLI – International Group for the Study of Lithium-treated patients).

As a clinician-researcher, her goals are to identify key risk factors and intermediate pathways influencing the risk of suicide and suicide attempts among high-risk population (e.g. people with psychiatric disorders), which could then inform novel early prevention strategies. She joined the editorial board of BMC Psychiatry as an Associate Editor for the Mood disorders section in 2011, and became a Deputy Section Editor for the same section in 2012. She was instrumental in establishing the Causes, treatment and prevention of suicide section of BMC Psychiatry, which launched in 2015 with Ute as Section Editor.

 

Joanne Ryan

Back to top

New Content ItemGeriatric psychiatry and cognitive disorders


Dr. Joanne Ryan is a genetic epidemiologist who leads the Dementia Research Program in the School of Public Health & Preventive Medicine, Monash University. She holds honorary fellow positions at the Murdoch Childrens Research Institute (Disease Epigenetics Group), and Inserm U1061, France (Neuropsychiatry: epidemiological and clinical research institute). Her qualifications include a PhD in Neuropsychiatric Epidemiology (University of Melbourne, Australia and Université Montpellier 1, France), a Masters of Biostatistics (Monash University) and a Bachelor of Science degree with honours in Molecular Biology (University of Melbourne). Her research is focused on the identification of risk factors and biomarkers for later-life neuropsychiatric disorders, and is at the interface between biomedical and public health research. She is an investigator on a number of longitudinal cohort studies of cognitive function and psychiatric disorders, and leads dementia research in the ASPREE randomised controlled trial of >16,000 elderly. She joined the editorial board of BMC Psychiatry as an Associate Editor in 2014 and became a Section Editor in 2016


Wei Wang

Back to top

New Content ItemPersonality disorders and disorders of adult behavior


Dr. Wei Wang is Professor of Clinical Psychology and Psychiatry at Zhejiang University, China. He joined the Editorial Board of BMC Psychiatry as Section Editor in 2011.

 

Dr. Wang completed his Ph.D. in Clinical Neuroscience at the University of Liège, Belgium. Later he joined Anhui Provincial Hospital in Hefei, China and then Zhejiang University School of Medicine in Hangzhou, China for clinical practices and researches on neuropsychiatric disorders.

 

Dr. Wang and his crew members are focusing on personality traits and disorders, emotion components and disorders, dream experiences (nightmare and sexual dream) and disorders, and neurocognitive processes at cerebral and brainstem levels. His clinical researches involve the personality disorders, bipolar I and II disorders and schizophrenia and the like.